Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-02T11:37:42.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new study-record version was submitted on 2026-10-20, documenting a change to Study Status; the previously listed history date of 2026-09-24 was replaced. An NIH notice about terminology during a website transition also appeared.
    Difference
    0.5%
    Check dated 2026-10-26T11:08:36.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer’s software revision changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-19T11:46:54.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov website as revision v3.7.1 instead of v3.7.0.
    Difference
    0.0%
    Check dated 2026-10-12T14:24:55.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A new history entry dated 2026-09-22 introduces the Study Status section and is followed by a 2026-09-24 update; the 2026-09-01 entry was removed from the version history.
    Difference
    0.2%
    Check dated 2026-09-28T17:15:19.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the record history, signaling an update to the study record. The previous revision v3.6.6 is shown as the earlier version in the diff.
    Difference
    0.1%
    Check dated 2026-09-21T20:30:18.000Z thumbnail image

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.